Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04559230
Title Sacituzumab Govitecan in Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors The University of Texas Health Science Center at San Antonio
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST